Back to full portfolio

Novel diagnostic platform using cell-free mRNA to diagnose neuro-degenerative and other diseases.
WEBSITE
Founder(s)
Dr. Stephen Quake, Scripps Institute
THEME(S)
Emerging therapeutic platforms
SECTOR(S)
Healthcare
Investment Stage
Early
Company Status
Private
Superfluid DX

Perspectives

More about Superfluid DX

Perspectives

Superfluid Dx - Leveraging cf-mRNA for early disease detection

Superfluid Dx - Leveraging cf-mRNA for early disease detection

PR Newswire
Perspectives

WRQ Sciences and Superfluid Dx., Inc. Announce Completion of Oversubscribed Series A Financing in Breakthrough Alzheimer's Disease Diagnostic Company Superfluid Dx

December 20, 2023
PR Newswire
PR Newswire

WRQ Sciences and Superfluid Dx., Inc. Announce Completion of Oversubscribed Series A Financing in Breakthrough Alzheimer's Disease Diagnostic Company Superfluid Dx